A recent study indicates that individuals who stop using popular slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Published data in a prominent health publication points out that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.
"Users purchasing these medications need to be aware of the potential of fast weight regain when the medication ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original weight in about a year and a half.
Analyzing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.
Researchers point out that people who lose weight through dieting generally experience a less rapid weight regain—around 100 grams monthly—once they finish.
Understanding the Fast Regain
Doctors suggest the mechanism of the jabs explains the accelerated rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the body to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Disease?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, given the significant potential of relapse, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who say that the results "emphasize the long-term character of excess weight," similar to managing conditions like high blood pressure.
User Accounts
Users who have come off the medication describe a sudden return of cravings.
"I experienced a trigger activating and you become extremely hungry," described an individual.
This difficulty is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment.
Significant Adoption
Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is higher among women than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a permanent solution and long-term success likely depends on ongoing lifestyle management.
